Does DINUTUXIMAB Cause Neoplasm progression? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Neoplasm progression have been filed in association with DINUTUXIMAB (Unituxin). This represents 4.3% of all adverse event reports for DINUTUXIMAB.
29
Reports of Neoplasm progression with DINUTUXIMAB
4.3%
of all DINUTUXIMAB reports
6
Deaths
1
Hospitalizations
How Dangerous Is Neoplasm progression From DINUTUXIMAB?
Of the 29 reports, 6 (20.7%) resulted in death, 1 (3.4%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DINUTUXIMAB. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does DINUTUXIMAB Cause?
Pyrexia (144)
Off label use (95)
Neuroblastoma recurrent (76)
Pain (74)
Abdominal pain (60)
Hypotension (55)
Neuroblastoma (49)
Anaemia (47)
Aspartate aminotransferase increased (46)
Alanine aminotransferase increased (43)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which DINUTUXIMAB Alternatives Have Lower Neoplasm progression Risk?
DINUTUXIMAB vs DINUTUXIMAB BETA
DINUTUXIMAB vs DIOSMIN
DINUTUXIMAB vs DIOSMIN\HESPERIDIN
DINUTUXIMAB vs DIOVAN
DINUTUXIMAB vs DIOVAN HCT